JF
PRQR icon

Jump Financial’s ProQR Therapeutics PRQR Stock Holding History

Jump Financial’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,702
Closed -$70.8K – 1930
2024
Q4 		$70.8K Buy
+26,702
New +$84.8K ﹤0.01% 1554
2022
Q1 		– Sell
-45,200
Closed -$362K – 1835
2021
Q4 		$362K Buy
45,200
+27,900
+161% +$212K 0.02% 800
2021
Q3 		$145K Buy
+17,300
New +$113K 0.01% 932

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jump Financial's PRQR Position: Q1 2025 in Review

Jump Financial sold out of ProQR Therapeutics (PRQR) in Q1 2025, closing a stake of 26,702 shares — an estimated $70.8K sold.

Jump Financial first reported a position in PRQR in Q3 2021 and held it in 3 quarters. The position peaked at $362K in Q4 2021. 65 funds tracked by Wall St. Rank hold PRQR as of Q1 2025.

  • Jump Financial reported no remaining ProQR Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 26,702 ProQR Therapeutics shares in Q1 2025, an estimated $70.8K.
  • Jump Financial first reported a position in ProQR Therapeutics in Q3 2021 and held it in 3 quarters.
  • Jump Financial's ProQR Therapeutics position peaked at $362K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.